On July 7, 2022, Ontrak, Inc. accepted Dr. Robert Accordino's resignation effective July 29, 2022 from his role as Chief Medical Officer ("CMO") of the Company. Dr. Accordino has resigned from his CMO role to devote more time to his clinical practice and his resignation was not due to any disagreement on any matter relating to the Company's operations, policies, or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.262 USD | -1.21% | -21.32% | -34.66% |
Apr. 16 | Ontrak, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 16 | Transcript : Ontrak, Inc., Q4 2023 Earnings Call, Apr 16, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.66% | 12.64M | |
+14.10% | 81.84B | |
-30.15% | 70.69B | |
+9.37% | 29.03B | |
-11.90% | 16.97B | |
-0.36% | 16.83B | |
-1.12% | 15.28B | |
+5.90% | 12.41B | |
+35.78% | 12.26B | |
-4.20% | 11.86B |
- Stock Market
- Equities
- OTRK Stock
- News Ontrak, Inc.
- Ontrak, Inc. Announces Resignation of Robert Accordino as Chief Medical Officer, Effective July 29, 2022